Global Liposome Drug Delivery (Liposomes Drug Delivery) Market growing at a CAGR of 10.1% during 2018-2025

Posted on 2018-07-03 by Mark Hub in Pharmaceuticals // 0 Comments

Market Research HUB

Albany, US, July 3, 2018: The market for Liposome Drug Delivery is growing with the expansion of this Industry Sector Worldwide. Market Research Hub (MRH) has added a new report titled “Global Liposome Drug Delivery (Liposomes Drug Delivery) Market” which offer details about the current trends and analysis, as well as scope for the near future. This research study also covers information about the production, consumption and market share based on different active regions. Furthermore, an anticipated growth at a double-digit CAGR for the Liposome Drug Delivery sector is highlighted in the report which indicates a prosperous future.

Click Here to Get the Sample Copy of the Report@ https://www.marketresearchhub.com/enquiry.php?type=S&repid=1846157

This report studies the global Liposome Drug Delivery (Liposomes Drug Delivery) market status and forecast, categorizes the global Liposome Drug Delivery (Liposomes Drug Delivery) market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
In consideration of the global economic and pharma industry, the growth rate of Liposomes Drug Delivery market will keep high in the next several years. The revenue market size expected to be 3.6 billion USD in 2020 at a CAGR of 8.57%.

North America dominated the market with market share of 44.2% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12.85%.

Liposomes have been used in a broad range of pharmaceutical applications. Liposomes are showing particular promise as intracellular delivery systems for anti-sense molecules, ribosomes, proteins/peptides, and DNA. Liposomes with enhanced drug delivery to disease locations, by ability of long circulation residence times, are now achieving clinical acceptance. Also, liposomes promote targeting of particular diseased cells within the disease site.

Finally, liposomal drugs exhibit reduced toxicities and retain enhanced efficacy compared with free complements. Based on the pharmaceutical applications and available products, we can say that liposomes have definitely established their position in modern delivery systems.

The global Liposome Drug Delivery (Liposomes Drug Delivery) market is valued at 2400 million US$ in 2017 and will reach 5190 million US$ by the end of 2025, growing at a CAGR of 10.1% during 2018-2025.

The major manufacturers covered in this report
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Spectrum Pharmaceuticals
Shanghai New Asia

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Other
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Fungal Infection Therapy
Cancer & Tumor Therapy
Other

View Full Report with Table and Content@ https://www.marketresearchhub.com/report/global-liposome-drug-delivery-liposomes-drug-delivery-market-research-report-2018-report.html

Table of Contents

Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Research Report 2018
1 Liposome Drug Delivery (Liposomes Drug Delivery) Market Overview
1.1 Product Overview and Scope of Liposome Drug Delivery (Liposomes Drug Delivery)
1.2 Liposome Drug Delivery (Liposomes Drug Delivery) Segment by Type (Product Category)
1.2.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production Market Share by Type (Product Category) in 2017
1.2.3 Liposomal Doxorubicin
1.2.4 Liposomal Amphoteracin B
1.2.5 Liposomal Paclitaxel
1.2.6 Other
1.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Segment by Application
1.3.1 Liposome Drug Delivery (Liposomes Drug Delivery) Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Other
1.4 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market by Region (2013-2025)
1.4.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Liposome Drug Delivery (Liposomes Drug Delivery) (2013-2025)
1.5.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue Status and Outlook (2013-2025)
1.5.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Capacity, Production Status and Outlook (2013-2025)

2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Competition by Manufacturers
2.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production and Share by Manufacturers (2013-2018)
2.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue and Share by Manufacturers (2013-2018)
2.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Liposome Drug Delivery (Liposomes Drug Delivery) Manufacturing Base Distribution, Sales Area and Product Type
2.5 Liposome Drug Delivery (Liposomes Drug Delivery) Market Competitive Situation and Trends
2.5.1 Liposome Drug Delivery (Liposomes Drug Delivery) Market Concentration Rate
2.5.2 Liposome Drug Delivery (Liposomes Drug Delivery) Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Capacity and Market Share by Region (2013-2018)
3.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production and Market Share by Region (2013-2018)
3.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Liposome Drug Delivery (Liposomes Drug Delivery) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Liposome Drug Delivery (Liposomes Drug Delivery) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Liposome Drug Delivery (Liposomes Drug Delivery) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Liposome Drug Delivery (Liposomes Drug Delivery) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Liposome Drug Delivery (Liposomes Drug Delivery) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Liposome Drug Delivery (Liposomes Drug Delivery) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

Continued….. @@

Enquire Full Details about this Report@ https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1846157

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like pharmaceuticals market research and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick